期刊文献+

紫杉醇脂质体联合香菇多糖对顺铂灌注化疗失败的晚期乳腺癌恶性胸腹水的疗效 被引量:8

下载PDF
导出
摘要 目的探讨紫杉醇脂质体联合香菇多糖对顺铂(DDP)灌注化疗失败的晚期乳腺癌恶性胸腹水的疗效及安全性。方法选取55例DDP灌注化疗失败的晚期乳腺癌恶性胸腹水患者,将其按随机数字表法分为2组:联合组27例,紫杉醇脂质体100mg d1每周1次,香菇多糖6mg d2每周1次;单独组28例,仅用香菇多糖6mg d1每周1次,均进行4周治疗。结果治疗组总有效率为70.4%,优于单独组的42.9%(χ2=3.96,P<0.05)。2组不良反应均较轻且可耐受。结论对DDP灌注化疗失败的晚期乳腺癌恶性胸腹水患者,紫杉醇脂质体联合香菇多糖和单独灌注香菇多糖,其胸痛、骨髓抑制及胃肠道反应等不良反应均较轻,耐受性好,但前者疗效好于后者。
作者 熊戴群 王红
出处 《实用临床医学(江西)》 CAS 2016年第12期22-23,29,107,共4页 Practical Clinical Medicine
  • 相关文献

参考文献6

二级参考文献81

  • 1涂持坤,孟玉春,杨晓东,王卫,杨桂芝,徐虹,孙雪丽.卡铂用于腹腔化疗的药代动力学测定[J].中华妇产科杂志,1995,30(4):212-214. 被引量:6
  • 2韩克,江森,孙树三,乔乃安,章晓梅,郭玲玲,王美清,乔柏生,刘文军,邹立家,赵炎,张磊.卡铂多相脂质体腹腔注射对615小鼠U_(14)移植瘤腹膜后淋巴结和肺转移的抑制作用[J].现代妇产科进展,1995,4(2):112-115. 被引量:3
  • 3秦叔逵,龚新雷.晚期胃癌化疗的现状和新进展[J].临床肿瘤学杂志,2006,11(9):641-652. 被引量:268
  • 4Bree D,Panayiotis A,Theodoropoulos,et al.Treatment of ovarian cancer using intraperitoneal chemotherapy with taxanes:From laboratory dench to bedside[J].Cancer Treatment Revi,2006,32:471-482.
  • 5Roth AD,Ajani J.Decetaxel-based chemotherapy in the treatment of gastric cancer[J].Ann Oncol,2003,14:41-44.
  • 6Van Cutsem E,Moiseyenko VM,Tjulandin S,et al.Phase Ⅲ study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer:A report of the V325 Study Group[J].J Clin Oncol,2006,24(31):4991-4997.
  • 7Fushida S,Nao F,Kinami S,et al.Pharmacologic study of intraperitoneal docetaxel in gastric cancer with peritoneal dissemination[J].Gan Kagaku Ryoho,2002,29(10):1759-1763.
  • 8Marchettini P,Stuart OA,Mohamed F,et al.Docetaxel:pharmacok in etics and tissue levels after intraperitoneal and intravenous administration in a rat model[J].Cancer Chemother Pharmacol,2002,49:499-503.
  • 9Yonemura Y,Bandou E,Sawa T,et al.Neoadjuvant treatment of gastric cancer with peritoneal dissemination[J].Eur J Surg Oncol,2006,32(6):661-665.
  • 10Morgan RJ,Doroshow JH,Synold T,et al.Phase I trial of intraperitoneal docetaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavity[J].Clin Cancer Res,2003,9(16):5896-5901.

共引文献30

同被引文献57

引证文献8

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部